416 related articles for article (PubMed ID: 26176182)
41. [Effects of LPS-induced inflammation on differentiation of orbital pre-adipocytes in thyroid-associated ophthalmopathy].
Yi WS; Xu XL
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):156-61. PubMed ID: 21426847
[TBL] [Abstract][Full Text] [Related]
42. Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress.
Yoon JS; Lee HJ; Chae MK; Lee SY; Lee EJ
J Endocrinol; 2013 Feb; 216(2):145-56. PubMed ID: 23143154
[TBL] [Abstract][Full Text] [Related]
43. Downregulation of Caveolin-1 and Upregulation of Deiodinase 3, Associated with Hypoxia-Inducible Factor-1α Increase, Are Involved in the Oxidative Stress of Graves' Orbital Adipocytes.
Van Regemorter E; Joris V; Van Regemorter V; Marique L; Behets C; Lengelé B; Boschi A; Baldeschi L; Daumerie C; Many MC; Craps J
Thyroid; 2021 Apr; 31(4):627-637. PubMed ID: 32977740
[No Abstract] [Full Text] [Related]
44. An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' Orbitopathy.
Philipp S; Horstmann M; Hose M; Daser A; Görtz GE; Jesenek C; Flögel U; Hansen W; Bechrakis N; Banga JPS; Eckstein A; Berchner-Pfannschmidt U
Thyroid; 2022 Mar; 32(3):283-293. PubMed ID: 34779257
[No Abstract] [Full Text] [Related]
45. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
[TBL] [Abstract][Full Text] [Related]
46. Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO).
Rotondo Dottore G; Ionni I; Menconi F; Casini G; Sellari-Franceschini S; Nardi M; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2018 Jul; 41(7):815-820. PubMed ID: 29256181
[TBL] [Abstract][Full Text] [Related]
47. Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays.
Krieger CC; Kahaly GJ; Azam A; Klubo-Gwiezdzinska J; Neumann S; Gershengorn MC
Thyroid; 2022 Jan; 32(1):90-96. PubMed ID: 34714162
[No Abstract] [Full Text] [Related]
48. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
[TBL] [Abstract][Full Text] [Related]
49. Peripheral blood mononuclear cells - Can they provide a clue to the pathogenesis of Graves' Orbitopathy?
Basak M; Sanyal T; Kar A; Bhattacharjee P; Das M; Chowdhury S
Endocrine; 2022 Feb; 75(2):447-455. PubMed ID: 34545512
[TBL] [Abstract][Full Text] [Related]
50. Molecular biomarkers of Graves' ophthalmopathy.
Longo CM; Higgins PJ
Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
[TBL] [Abstract][Full Text] [Related]
51. Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.
Mimura LY; Villares SM; Monteiro ML; Guazzelli IC; Bloise W
Thyroid; 2003 Sep; 13(9):845-50. PubMed ID: 14588098
[TBL] [Abstract][Full Text] [Related]
52. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.
Wakelkamp IM; Bakker O; Baldeschi L; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2003 Mar; 58(3):280-7. PubMed ID: 12608932
[TBL] [Abstract][Full Text] [Related]
53. Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping.
Zhu H; Zou M; Wu D; Li B; Su Y; Li Y; Hong S; Yang Z
Eur Radiol; 2023 Dec; 33(12):9074-9083. PubMed ID: 37466707
[TBL] [Abstract][Full Text] [Related]
54. Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts.
Valyasevi RW; Jyonouchi SC; Dutton CM; Munsakul N; Bahn RS
J Clin Endocrinol Metab; 2001 Feb; 86(2):903-8. PubMed ID: 11158064
[TBL] [Abstract][Full Text] [Related]
55. Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications.
Bartalena L; Tanda ML; Piantanida E; Lai A
Biofactors; 2003; 19(3-4):155-63. PubMed ID: 14757966
[TBL] [Abstract][Full Text] [Related]
56. Immunological Aspects of Graves' Ophthalmopathy.
Łacheta D; Miśkiewicz P; Głuszko A; Nowicka G; Struga M; Kantor I; Poślednik KB; Mirza S; Szczepański MJ
Biomed Res Int; 2019; 2019():7453260. PubMed ID: 31781640
[TBL] [Abstract][Full Text] [Related]
57. Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy.
Chen MH; Chen MH; Liao SL; Chang TC; Chuang LM
Clin Endocrinol (Oxf); 2008 Aug; 69(2):332-7. PubMed ID: 18284633
[TBL] [Abstract][Full Text] [Related]
58. Intestinal permeability is associated with aggravated inflammation and myofibroblast accumulation in Graves' orbitopathy: the MicroGO study.
Fenneman AC; van der Spek AH; Hartstra A; Havik S; Salonen A; de Vos WM; Soeters MR; Saeed P; Nieuwdorp M; Rampanelli E
Front Endocrinol (Lausanne); 2023; 14():1173481. PubMed ID: 38107520
[TBL] [Abstract][Full Text] [Related]
59. Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen.
Berchner-Pfannschmidt U; Moshkelgosha S; Diaz-Cano S; Edelmann B; Görtz GE; Horstmann M; Noble A; Hansen W; Eckstein A; Banga JP
Endocrinology; 2016 Apr; 157(4):1673-82. PubMed ID: 26872090
[TBL] [Abstract][Full Text] [Related]
60. Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
Moshkelgosha S; Verhasselt HL; Masetti G; Covelli D; Biscarini F; Horstmann M; Daser A; Westendorf AM; Jesenek C; Philipp S; Diaz-Cano S; Banga JP; Michael D; Plummer S; Marchesi JR; Eckstein A; Ludgate M; Berchner-Pfannschmidt U;
Microbiome; 2021 Feb; 9(1):45. PubMed ID: 33593429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
